Clinical trials with 2,3-dihydroxybenzoic acid.
D002614:Chelating Agents; D004341:Drug Evaluation; D006801:Humans; D062385:Hydroxybenzoates / Q000097:blood / Q000627:therapeutic use* / Q000633:toxicity; D007501:Iron / Q000097:blood; D013789:Thalassemia / Q000188:drug therapy*
D002614:Chelating Agents; D062385:Hydroxybenzoates; D007501:Iron